Personalised therapy reduces the risk of cardiovascular disease for diabetics
Tuesday, October 8, 2013 - 11:30
in Health & Medicine
600,000 to 800,000 Austrians suffer from diabetes mellitus. Thanks to the biomarker known as NT-proBNP (a hormone specific to the heart), the sub-group of people who are at increased risk of cardiovascular disease can be determined even though their hearts appear to be healthy. This group accounts for around 40 per cent of all diabetics.